Skip to content

PAR-25-317 family health R01 eligibility Guide

Updated 7 official sources

Quick Answer: PAR-25-317 is an NIH R01 for family health, family well-being, family resilience, and family-level intervention research focused on NIH-designated populations experiencing health disparities in the United States.

Full answer and how we checked it

It is clinical trial optional and can support up to 5 years. The 2026 decision turns on 7 checks.

Who this is for: Minority health researchers, social and behavioral science teams, nursing researchers, cancer prevention groups, alcohol research teams, community-engaged research offices, and sponsored-research teams deciding whether family-level R01 scope fits.

Data note: This guide uses NIH PAR-25-317, NIH NOT-MD-27-001, NIH NOT-OD-26-029, Grants.gov listing 357713, and NIH RePORTER award records checked on October 10, 2026.

In this guide

Quick Facts

Agency
HHS
Deadline
Mar 6, 2027
Status
Open

Assistance Listing 93.361: all awards

Source: USASpending.gov FY2024

These figures cover all National Institutes of Health awards under Assistance Listing 93.361, of every award type. They are not figures for the award this guide describes, and one award of that kind can be far smaller.

Total Awards (FY2024, whole listing)
6
Avg Award (whole listing)
$2,220,685
Median Award (whole listing)
$2,735,186

Data last verified: May 22, 2026

PAR-25-317 is not a general family services grant. NIH frames it around research on family health, family well-being, and family resilience, with projects expected to include family health measures for two or more family members and focus on families from NIH-designated populations experiencing health disparities in the United States.

Use this guide with the live Family Health Risk and Protective Factors R01 program record. Then compare NIH grants complete guide, NIH R01 R21 R03 K awards comparison, what is a NOFO, Healthcare Grants Complete Guide, and the Grantsights grant database.

Source Check

Checked October 2026.

As of October 10, 2026, PAR-25-317 is still accepting applications, but it's closing early. On September 24, 2026, NIMHD issued NOT-MD-27-001 (opens in a new tab), which moves the expiration date from May 8, 2027 to March 6, 2027. The June 5 and October 5, 2026 new-application dates have passed. That leaves February 5, 2027 as the last new-application date, and November 5, 2026 and March 5, 2027 as the last renewal, resubmission, and revision dates. All applications are due by 5 p.m. local time of the applicant organization.

A new application submitted February 5, 2027 can't be resubmitted under this NOFO, so plan another route if an A1 is likely.

The source also reflects NIH's removal of AIDS application due dates from this NOFO. That matters for copied research-office calendars: as of the current source, 2026 and 2027 AIDS columns are not applicable.

7 PAR-25-317 Eligibility Stop Checks

Within 21 days, use this section as the checkpoint for the family-level R01 before a team treats an individual-health study as family research.

7 stop checks decide whether this route fits.

Stop checkStrong R01 signalRed flag
Family levelMeasures include two or more family membersOnly one patient's outcome is measured
PopulationNIH-designated disparities population is centralPopulation fit is vague
Research scopeObservational or intervention study fits R01 scaleService program with no research design
Conceptual modelPathways from family factors to outcomes are definedFamily is only a setting
MeasuresFamily health, behavior, or outcome measures are namedMeasurement plan is thin
Trial statusClinical trial optional and justified either wayTrial status is unclear
Animal modelsNot usedAnimal model study
Family definitionTwo or more family members are measuredFamily appears only as context
Date planningNovember 5, 2026 or February 5, 2027 is realisticCalendar still shows the May 8, 2027 expiration

The route is strongest when the study can explain the family unit, pathways, measures, and outcomes in one page.

5 Source Facts Applicants Should Know

Within 21 days, use this section as the checkpoint for the family-level R01 before a team treats an individual-health study as family research.

FactSource-backed read
Funding numberPAR-25-317
MechanismR01 Research Project Grant
Clinical trial statusOptional
BudgetNot limited, but must reflect actual needs
ExpirationMarch 6, 2027 (moved up by NOT-MD-27-001)
Last new dateFebruary 5, 2027
Remaining resubmission datesNovember 5, 2026 and March 5, 2027

NIH says the maximum project period is 5 years. Before you draft, search NIH RePORTER (opens in a new tab) for projects already funded under this notice to see the scope and team size that reviewers have backed.

What PAR-25-317 Has Funded So Far

Grantsights checked NIH RePORTER (opens in a new tab) on October 10, 2026 and found 6 FY2026 awards under PAR-25-317. Total first-year costs ran from $496,472 to $776,071. Two of the six were funded on resubmission (A1).

AwardOrganizationInstituteFY2026 total costFocus
1R01MD021606-01Morehouse School of MedicineNIMHD$702,086Diabetes prevention using genetics and family history
1R01MD020419-01A1Ponce School of MedicineNIMHD$776,071Prenatal stress management and parenting (SMART-PREP)
1R01MD021505-01UT Southwestern Medical CenterNIMHD$496,472Family-level hypertension intervention (Walk Together trial)
1R01CA315485-01UT MD Anderson Cancer CenterNCI$690,715Randomized trial for families coping with parental cancer
1R01CA308143-01A1UT MD Anderson Cancer CenterNCI$706,777IGNITE-TX
1R01NR022314-01Case Western Reserve UniversityNINR$649,283EHR-informed risk assessment of intimate partner violence

Most of these are intervention studies with a defined family unit and a named disease or risk outcome. Grantsights analysis of these records also shows no FY2026 award under this NOFO from NIAAA, a participating institute, so alcohol-focused teams should check with NIAAA program staff first.

NOFO Requirements That Go Beyond a Standard R01

According to PAR-25-317 (opens in a new tab), these requirements are specific to this notice:

  • Conceptual model. Studies should show the pathways between the family level, other determinants, and health outcomes.
  • PhenX measures. PhenX Toolkit measures for individual demographic factors are required; its Social Determinants of Health collections are strongly encouraged.
  • Domestic applicants only. Foreign organizations can't apply, though foreign components are allowed.
  • Multiple applications. An institution can submit more than one, as long as each is scientifically distinct.

Reviewers score Factor 1 (importance) and Factor 2 (rigor and feasibility) separately and weigh Factor 3 (expertise and resources) in overall impact. A common mistake is treating the family as a recruitment channel, which Factor 2 reviewers read as a thin measurement plan.

What NIH Doesn't Tell You

Within 21 days, use this section as the checkpoint for the family-level R01 before a team treats an individual-health study as family research.

4 practical questions decide whether the study belongs here.

First, the unit of analysis must be real. If the study measures only one person and treats family context as background, it may not fit the route's purpose.

Second, the population focus cannot be vague. NIH expects families from one or more NIH-designated populations experiencing health disparities in the United States.

Third, the conceptual model matters. The application should show how family-level risk factors, protective factors, resilience, social conditions, care patterns, or communication pathways influence health outcomes.

Fourth, partner roles should match the research question. Community organizations, clinicians, public health agencies, social service groups, and faith-based organizations can matter when they improve the study design and use of results.

6 Evidence Assets That Make This R01 Stronger

Within 21 days, use this section as the checkpoint for the family-level R01 before a team treats an individual-health study as family research.

6 evidence assets make this R01 easier to defend. The first is a family definition. State who is included, why, and how relationships are measured.

The second is a disparities-population memo. It should name the population, evidence base, recruitment setting, and equity-related measurement issues.

The third is a conceptual model diagram. It should connect family-level risk and protective factors to health behaviors, service use, disease outcomes, well-being, resilience, or prevention.

The fourth is a measurement table. Include outcomes for at least two family members, family-level measures, timing, data source, and respondent burden.

The fifth is a partner plan. If community, clinic, public health, or social service partners are involved, state their role in design, recruitment, interpretation, and use.

The sixth is a trial-status decision.

5 Route Choices Before Drafting

Within 21 days, use this section as the checkpoint for the family-level R01 before a team treats an individual-health study as family research.

5 routes should be compared before a team drafts.

RouteBetter first read when...Why
PAR-25-317 R01Family-level measures and disparities focus are centralRoute fits
Parent R01Family route is not needed or topic is broaderActive broad route may fit
NIMHD routeDisparities science is central but not family-levelMission fit may differ
NCI or NIAAA routeCancer or alcohol questions lead the designParticipating institute may shape fit
Community service grantMain work is service delivery, not researchNIH R01 may not fit

6 Bad-Fit Signals

Within 21 days, use this section as the checkpoint for the family-level R01 before a team treats an individual-health study as family research.

6 bad-fit signals should be visible. First, the project studies only one individual and calls the setting family-based.

Second, the study does not focus on NIH-designated populations experiencing health disparities in the United States. Third, the conceptual model is missing. Fourth, the project uses animal models. Fifth, the work is only a service program. Sixth, trial status is not resolved for an intervention study.

Those stop checks protect applicant time.

21-Day Family-Level R01 Plan

Within 21 days, use this section as the checkpoint for the family-level R01 before a team treats an individual-health study as family research.

Days 1 through 3 should confirm source status, the March 6, 2027 expiration, due dates, clinical-trial status, budget, and participating institute interests.

Days 4 through 7 should define the family unit and the disparities population. The team should explain why the family unit is the right focus.

Days 8 through 12 should build the conceptual model and measurement table. Include outcomes for two or more family members.

Days 13 through 16 should map partners, recruitment, retention, data collection, and respondent burden.

Days 17 through 21 should compare route choice and draft the program-staff memo, especially if the project includes an intervention or clinical trial.

7 Above-the-Fold Claims That Need Proof

Within 21 days, the first screen should prove 7 claims: what the route funds, whether the source is open or expired, whether clinical trials are allowed, what budget rule applies, who is eligible in practice, what does not fit, and what route should be compared next.

According to NIH in the NOFO (opens in a new tab), this source should be treated as the authority for rules.

7 Route Checks

Added June 2, 2026.

Checked on June 2, 2026 against PAR-25-317 (opens in a new tab), NOT-OD-26-029 (opens in a new tab), the Grants.gov listing (opens in a new tab), USASpending.gov (opens in a new tab), and USASpending.gov (opens in a new tab).

CheckPublic answer
EligibilityConfirm the applicant, institution, and route rules for PAR-25-317 family health R01 eligibility.
Source statusVerify the official listing, notices, due date, and expiration status.
BudgetCheck award size, cost limits, match, or budget logic when the source provides it.
EvidenceName the data, preliminary work, partner role, or implementation proof needed.
Bad fitStop if the project belongs in a nearby NIH or federal route.
Review criteriaTie the first page to significance, approach, team, environment, and source-specific criteria.
Next actionDecide whether to draft, ask a program contact, redirect, or move to a nearby route.

Final public checklist

  • Confirm whether R01 is the right route or whether a nearby program fits better.
  • Check budget, partner, match, or data-readiness constraints.

Sources

Largest awards active in FY2024

One row per recipient, its largest award | 6 Assistance Listing records | Avg: $2.2M

REAL DATA
1

University of Washington

WA

$79.0M
2

Regents of the University of California, San Francisco, the

CA

$78.9M

Use the visible recipient rows as free source context

This program has no reviewed paid report today.

No reviewed paid report is currently offered for this program. The visible source rows remain free.

Next steps

Where to go next

These next pages help you move from research into a specific grant choice.

Frequently Asked Questions

What does PAR-25-317 fund?

It funds R01 research on family health, family well-being, family resilience, risk factors, protective factors, and family-level intervention studies.

Are clinical trials allowed?

Yes. PAR-25-317 is clinical trial optional.

What populations must be included?

Projects must focus on families from one or more NIH-designated populations experiencing health disparities in the United States.

What budget applies?

NIH says application budgets are not limited but must reflect the actual needs of the project, with a maximum project period of 5 years.

Who should skip this route?

Skip it if the project studies only individual outcomes, lacks family-level measures for at least two family members, or uses animal models.

Last updated October 10, 2026. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.